Daniel P. Van Plew - 09 Aug 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**Daniel P. Van Plew
Issuer symbol
REGN
Transactions as of
09 Aug 2021
Net transactions value
-$8,642,814
Form type
4
Filing time
10 Aug 2021, 17:54:25 UTC
Next filing
17 Nov 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $6,760,750 +25,000 +93% $270.43 51,931 09 Aug 2021 Direct
transaction REGN Common Stock Tax liability $11,363,459 -18,397 -35% $617.68 33,534 09 Aug 2021 Direct
transaction REGN Common Stock Sale $147,986 -244 -0.73% $606.50 33,290 10 Aug 2021 Direct F1
transaction REGN Common Stock Sale $462,694 -762 -2.3% $607.21 32,528 10 Aug 2021 Direct F2
transaction REGN Common Stock Sale $424,124 -697 -2.1% $608.50 31,831 10 Aug 2021 Direct F3
transaction REGN Common Stock Sale $121,850 -200 -0.63% $609.25 31,631 10 Aug 2021 Direct F4
transaction REGN Common Stock Sale $61,081 -100 -0.32% $610.81 31,531 10 Aug 2021 Direct
transaction REGN Common Stock Sale $244,628 -400 -1.3% $611.57 31,131 10 Aug 2021 Direct F5
transaction REGN Common Stock Sale $551,205 -900 -2.9% $612.45 30,231 10 Aug 2021 Direct F6
transaction REGN Common Stock Sale $981,344 -1,600 -5.3% $613.34 28,631 10 Aug 2021 Direct F7
transaction REGN Common Stock Sale $688,050 -1,120 -3.9% $614.33 27,511 10 Aug 2021 Direct F8
transaction REGN Common Stock Sale $172,262 -280 -1% $615.22 27,231 10 Aug 2021 Direct F9
transaction REGN Common Stock Sale $184,881 -300 -1.1% $616.27 26,931 10 Aug 2021 Direct F10
holding REGN Common Stock 1,048 09 Aug 2021 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -25,000 -50% $0.000000 25,000 09 Aug 2021 Common Stock 25,000 $270.43 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents volume-weighted average price of sales of 244 shares of Company stock on August 10, 2021 at prices ranging from $606.32 to $606.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
F2 Represents volume-weighted average price of sales of 762 shares of Company stock on August 10, 2021 at prices ranging from $607.00 to $607.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
F3 Represents volume-weighted average price of sales of 697 shares of Company stock on August 10, 2021 at prices ranging from $608.17 to $608.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
F4 Represents volume-weighted average price of sales of 200 shares of Company stock on August 10, 2021 at prices ranging from $609.21 to $609.29. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
F5 Represents volume-weighted average price of sales of 400 shares of Company stock on August 10, 2021 at prices ranging from $611.22 to $611.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
F6 Represents volume-weighted average price of sales of 900 shares of Company stock on August 10, 2021 at prices ranging from $612.03 to $612.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
F7 Represents volume-weighted average price of sales of 1,600 shares of Company stock on August 10, 2021 at prices ranging from $613.07 to $613.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
F8 Represents volume-weighted average price of sales of 1,120 shares of Company stock on August 10, 2021 at prices ranging from $614.08 to $614.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
F9 Represents volume-weighted average price of sales of 280 shares of Company stock on August 10, 2021 at prices ranging from $615.00 to $615.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
F10 Represents volume-weighted average price of sales of 300 shares of Company stock on August 10, 2021 at prices ranging from $616.01 to $616.51. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
F11 The stock option award vests in four equal annual installments, commencing one year after the date of grant.